Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-02-21
1987-12-15
Daus, Donald G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
514288, A61K 3148, C07D45700
Patent
active
047134577
ABSTRACT:
Novel ergoline derivatives and acid addition salts thereof are disclosed. These ergoline derivatives possess excellent anti-hypertensive activity, vasodilating activity, anti-ulcer activity, gastric secretion inhibitory activity, brain metabolism improving activity, anti-depressive activity and dopamine-like activity, and, therefore, are useful for prevention and treatment of various diseases such as hypertension, a wide variety of vein disorders, peptic ulcer, brain absormality, depression, Parkinson's disease, high prolactin blood disease, etc.
REFERENCES:
patent: 4199579 (1980-04-01), Ferrari et al.
patent: 4321381 (1982-03-01), Mantegani et al.
Bernardi et al, "Antihypertensive Ergolinepropionamides", Arzneim.-Forsch., vol. 33 (1983), pp. 1094-1098.
"10-Methoxyergoline Derivatives as a-Adrenergic Blocking Agents", Experimentia, vol. 28, pp. 819-823.
Salvati et al, "Cardiovascular Effects of a New Antihypertensive Agent in Several Species", Arzneim.-Forsch., vol. 33 (1983), pp. 1098-1107.
Hollenberg, "The Kidney and Strategies for the Treatment of Hypertension", vol. 77(4a), (10/5/84), pp. 60-63.
Weinstock et al, "Synthesis and Renal Vasodilator . . . Fenoldopam", vol. 29 (1986), pp. 2315-2325.
Jap. J. Pharmacol., 40 (Suppl.) (1986), p. 174.
Folia Pharmacol., Japan, vol. 87 (1986), pp. 445-456.
Seiler et al, "Structure-Activity Relationship of . . . Substituents", J. Med. Chem., vol. 29 (1986), pp. 912-917.
Stumpe et al, "Hyperprolactinaemia and . . . Hypertension", The Lancet, Jul. 30, 1977, pp. 211-214.
Lievre et al, "Einfluss auf die zerebrale . . . Nicergolin", Arzneim.-Forsch., vol. 29 (1979), pp. 1227-1231.
Cassady et al, "Ergot Alkaloids . . . Release", J. Med. Chem., vol. 17, No. 3, (1974), pp. 300-307.
Stutz et al, "Ergot Alkaloids. New Ergolines . . . Stimulants", J. Med. Chem., vol. 21, No. 8, (1978), pp. 754-757.
Sanka to Fujinka, vol. 48 (1981), pp. 117-123, 241.
Yakuri to Chiryo, vol. 12, No. 1 (1/84), pp. 401-407.
Crider et al, "Convenient Synthesis . . . Ester", Journal of Pharmaceutical Science, vol. 70, No. 12 (12/81), pp. 1319-1321.
Benez et al, "2-Acylated Derivatives of Ergoline", Collection Czechoslovak Chem. Commun., vol. 47 (1982), pp. 1757-1761.
Beran et al, Collection, Czechoslov. Chem. Commun., vol. 42 (1977), pp. 1407-1411.
Beran et al, "Some O-Acyl Derivatives . . . Ergoline(I)", Collection Czechoslov. Chem. Commun., vol. 39 (1974), pp. 1768-1772.
Calne et al, "Bromocriptine in Parkinsonism", British Med. Journal, vol. 4 (1974), pp. 442-444.
Fluckiger et al, "Two Novel Prolactin Release-Inhibiting . . . ", Experientia, vol. 35 (1979), pp. 1677-1678.
Crider et al, Ergot Alkaloids, J. Med. Chem. 1977, vol. 20, No. 11, pp. 1473-1477.
Sved et al, "Evidence for a Peripheral . . . Lergotrile", Life Sciences, vol. 27, (1981), pp. 349-354.
Cavero et al, "Pergolide Decreases Arterial . . . Dogs", Br. J. Pharmacol., vol. 75 (1982), pp. 142-143.
Moretti, "Metabolische und . . . Zentralnervensystem", Arzneim.-Forsch., vol. 29 (1979), pp. 1213-1223.
Enz, "Biphasic Influence . . . Rat", Life Sciences, vol. 29 (1981), pp. 2227-2234.
Snider, "Correlation of Behavioural Inhibition . . . Turnover", J. Pharm Pharmacol. (1976), pp. 563-566.
Li et al, "Ergot Akaloids . . . Release", Journal of Medicinal Chemistry, vol. 18, No. 9 (1975), pp. 892-895.
Manske, "The Alkaloids", vol. XV (1975), pp. 1-40.
Ban Takao
Ebihara Yuko
Ichihara Kenji
Mizukoshi Kiyoshi
Nagasaka Mitsuaki
Daus Donald G.
Maruko Seiyaku Co., Ltd.
Shen Cecilia
LandOfFree
Ergoline derivatives and acid addition salts thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ergoline derivatives and acid addition salts thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergoline derivatives and acid addition salts thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1221100